Geode Capital Management’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
Other funds holding LEXX
ICM
VCM
VFT
XT
KF
Geode Capital Management's LEXX Position: Q1 2026 in Review
Geode Capital Management increased its Lexaria Bioscience (LEXX) stake by 34% in Q1 2026, buying an estimated $54K and bringing the position to 19,610 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #3866.
Geode Capital Management first reported a position in LEXX in Q2 2021 and has held it in 20 quarters since. The position peaked at $459K in Q3 2024. 25 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.
- Geode Capital Management held 19,610 shares of Lexaria Bioscience worth $229K as of Q1 2026.
- Geode Capital Management bought 4,962 Lexaria Bioscience shares in Q1 2026, an estimated $54K.
- Lexaria Bioscience made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3866 holding.
- Geode Capital Management first reported a position in Lexaria Bioscience in Q2 2021 and has held it in 20 quarters since.
- Geode Capital Management's Lexaria Bioscience position peaked at $459K in Q3 2024.
- 25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.